Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Mi Jang"
Filter
Filter
Article category
Publication year
Case Report
Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
Choong Hee Kim, Gwang Hyeon Choi, Hee Young Na, Chang Jin Yoon, Jai Young Cho, Sangmi Jang, Ji Hye Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
J Liver Cancer. 2022;22(2):194-201.   Published online September 15, 2022
DOI: https://doi.org/10.17998/jlc.2022.08.24
  • 3,135 Views
  • 67 Downloads
AbstractAbstract PDF
Membranous obstruction of the inferior vena cava (MOVC) is a rare subset of Budd-Chiari syndrome (BCS) with a subacute onset that is often complicated by cirrhosis and hepatocellular carcinoma (HCC). Here we report a case of recurrent HCC in a patient with cirrhosis and BCS that was treated with several episodes of transarterial chemoembolization followed by surgical tumorectomy, whereas the MOVC was successfully treated with balloon angioplasty followed by endovascular stenting. The patient was followed up for 9.9 years without anticoagulation and experienced no stent thrombosis. After the tumorectomy, the patient was HCC-free for 4.4 years of follow-up.
Close layer
Review Article
Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors
Haeryoung Kim, Mi Jang, Young Nyun Park
J Liver Cancer. 2020;20(1):17-24.   Published online March 31, 2020
DOI: https://doi.org/10.17998/jlc.20.1.17
  • 15,797 Views
  • 1,065 Downloads
  • 33 Citations
AbstractAbstract PDF
Hepatocellular carcinoma (HCC) is heterogeneous in pathogenesis, phenotype and biological behavior. Various histopathological features of HCC had been sporadically described, and with the identification of common molecular alterations of HCC and its genomic landscape over the last decade, morpho-molecular correlation of HCC has become possible. As a result, up to 35% of HCCs can now be classified into histopathological variants, many of which have unique molecular characteristics. This review will provide an introduction to the variously described histopathological variants of HCC in the updated WHO Classification of Digestive System Tumors.

Citations

Citations to this article as recorded by  
  • Computational pathology: A survey review and the way forward
    Mahdi S. Hosseini, Babak Ehteshami Bejnordi, Vincent Quoc-Huy Trinh, Lyndon Chan, Danial Hasan, Xingwen Li, Stephen Yang, Taehyo Kim, Haochen Zhang, Theodore Wu, Kajanan Chinniah, Sina Maghsoudlou, Ryan Zhang, Jiadai Zhu, Samir Khaki, Andrei Buin, Fatemeh
    Journal of Pathology Informatics.2024; 15: 100357.     CrossRef
  • Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
    Bokyung Ahn, Hee‐Sung Ahn, Jinho Shin, Eunsung Jun, Eun‐Young Koh, Yeon‐Mi Ryu, Sang‐Yeob Kim, Chang Ohk Sung, Ju Hyun Shim, JeongYeon Hong, Kyunggon Kim, Hyo Jeong Kang
    Liver International.2024; 44(5): 1202.     CrossRef
  • Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation
    Wanjing Zheng, Xiaodan Chen, Meilian Xiong, Yu Zhang, Yang Song, Dairong Cao
    Journal of Magnetic Resonance Imaging.2024;[Epub]     CrossRef
  • Diagnostic Model for Proliferative HCC Using LI‐RADS: Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI Combination
    Mengtian Lu, Zuyi Yan, Qi Qu, Guodong Zhu, Lei Xu, Maotong Liu, Jifeng Jiang, Chunyan Gu, Ying Chen, Tao Zhang, Xueqin Zhang
    Journal of Magnetic Resonance Imaging.2024;[Epub]     CrossRef
  • A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements
    Suayib Yalcin, Sahin Lacin, Ahmed Kaseb, Bora Peynircioğlu, Murat Cantasdemir, Barbaros Çil, Pervin Hurmuz, Ahmet Doğrul, Murat Bozkurt, Hüseyin Abali, Okan Akhan, Halis Şimşek, Berksoy Sahin, Faruk Aykan, İdris Yücel, Gürkan Tellioğlu, Fatih Selçukbirici
    Journal of Hepatocellular Carcinoma.2024; Volume 11: 953.     CrossRef
  • The impact of matrix stiffness on hepatic cell function, liver fibrosis, and hepatocellular carcinoma—Based on quantitative data
    Kiyoon Min, Sathish Kumar Karuppannan, Giyoong Tae
    Biophysics Reviews.2024;[Epub]     CrossRef
  • Gadoxetic Acid-Enhanced MRI-Based Radiomic Models for Preoperative Risk Prediction and Prognostic Assessment of Proliferative HCC
    Zuyi Yan, Zixin Liu, Guodong Zhu, Mengtian Lu, Jiyun Zhang, Maotong Liu, Jifeng Jiang, Chunyan Gu, Xiaomeng Wu, Tao Zhang, Xueqin Zhang
    Academic Radiology.2024;[Epub]     CrossRef
  • CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment
    Gongzheng Wang, Feier Ding, Kaige Chen, Zhuoshuai Liang, Pengxi Han, Linxiang Wang, Fengyun Cui, Qiang Zhu, Zhaoping Cheng, Xingzhi Chen, Chencui Huang, Hongxia Cheng, Ximing Wang, Xinya Zhao
    Journal of Translational Medicine.2024;[Epub]     CrossRef
  • Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma
    Joo Hyun Oh, Dong Hyun Sinn
    Journal of Liver Cancer.2024; 24(2): 126.     CrossRef
  • Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
    Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Fabio Piscaglia, Laura Gramantieri
    Cancers.2023; 15(6): 1661.     CrossRef
  • Non-alcoholic fatty liver disease: the pathologist’s perspective
    Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
    Clinical and Molecular Hepatology.2023; 29(Suppl): S302.     CrossRef
  • 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

    Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
  • Three-dimensional multifrequency magnetic resonance elastography improves preoperative assessment of proliferative hepatocellular carcinoma
    Guixue Liu, Di Ma, Huafeng Wang, Jiahao Zhou, Zhehan Shen, Yuchen Yang, Yongjun Chen, Ingolf Sack, Jing Guo, Ruokun Li, Fuhua Yan
    Insights into Imaging.2023;[Epub]     CrossRef
  • Lymphocyte-Rich Hepatocellular Carcinoma with Multiple Lymphadenopathy and Positive Epstein–Barr Virus Encoding Region
    Pin-Yi Wang, Yu-Hsuan Kuo, Ming-Jen Sheu, Hsing-Tao Kuo, Wen-Ying Lee, Yu-Ting Kuo, Su-Hung Wang, Zu-Yau Lin
    Case Reports in Hepatology.2023; 2023: 1.     CrossRef
  • Genome-Wide Extrachromosomal Circular DNA Profiling of Paired Hepatocellular Carcinoma and Adjacent Liver Tissues
    Jianyu Ye, Peixin Huang, Kewei Ma, Zixin Zhao, Ting Hua, Wenjing Zai, Jieliang Chen, Xiutao Fu
    Cancers.2023; 15(22): 5309.     CrossRef
  • Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M
    Subin Heo, Hyo Jeong Kang, Sang Hyun Choi, Sehee Kim, Youngeun Yoo, Won-Mook Choi, So Yeon Kim, Seung Soo Lee
    European Radiology.2023; 34(5): 2974.     CrossRef
  • ФИБРОЛАМЕЛЛЯРНАЯ ГЕПАТОЦЕЛЛЮЛЯРНАЯ КАРЦИНОМА
    М.Т. Orucov, E.T. Şamdancı, Ə.B. Həsənov
    Azerbaijan Medical Journal.2023; (3): 172.     CrossRef
  • Cellular heterogeneity and plasticity in liver cancer
    Lo-Kong Chan, Yu-Man Tsui, Daniel Wai-Hung Ho, Irene Oi-Lin Ng
    Seminars in Cancer Biology.2022; 82: 134.     CrossRef
  • MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification
    Ja Kyung Yoon, Jin-Young Choi, Hyungjin Rhee, Young Nyun Park
    European Radiology.2022; 32(8): 5119.     CrossRef
  • Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review
    Liang Meng Loy, Hsien Min Low, Jin-Young Choi, Hyungjin Rhee, Chin Fong Wong, Cher Heng Tan
    American Journal of Roentgenology.2022; 219(2): 212.     CrossRef
  • Paraneoplastic syndromes in hepatocellular carcinoma: a review
    Yuki Ong, Cheong Wei Terence Huey, Vishalkumar Girishchandra Shelat
    Expert Review of Gastroenterology & Hepatology.2022; 16(5): 449.     CrossRef
  • Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
    Venkata S. Katabathina, Lokesh Khanna, Venkateswar R. Surabhi, Marta Minervini, Krishna Shanbhogue, Anil K. Dasyam, Srinivasa R. Prasad
    RadioGraphics.2022; 42(5): 1338.     CrossRef
  • 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

    Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
  • 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

    Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
  • Histomorphological Subtypes of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Review and Update
    Yoon Jung Hwang, Haeryoung Kim
    AJSP: Reviews and Reports.2022; 27(6): 234.     CrossRef
  • Pediatric Primary Hepatic Tumors: Diagnostic Considerations
    Bryony Lucas, Sanjita Ravishankar, Irina Pateva
    Diagnostics.2021; 11(2): 333.     CrossRef
  • A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
    Jae Won Song, Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Young Nyun Park, Dai Hoon Han, Do Young Kim
    Journal of Liver Cancer.2021; 21(1): 69.     CrossRef
  • HCC You Cannot See
    Vaishnavi Boppana, Sakshi Sahni, Joseph Glass, Christopher Chang, Denis M McCarthy
    Digestive Diseases and Sciences.2021; 66(7): 2185.     CrossRef
  • An update on subtypes of hepatocellular carcinoma: From morphology to molecular
    Monika Vyas, Dhanpat Jain
    Indian Journal of Pathology and Microbiology.2021; 64(5): 112.     CrossRef
  • HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy
    Sandeep Arora, Roberta Catania, Amir Borhani, Natally Horvat, Kathryn Fowler, Carla Harmath
    Abdominal Radiology.2021; 46(8): 3686.     CrossRef
  • Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery
    Hyo-Jin Kang, Haeryoung Kim, Dong Ho Lee, Bo Yun Hur, Yoon Jung Hwang, Kyung-Suk Suh, Joon Koo Han
    Radiology.2021; 300(3): 572.     CrossRef
  • Radiologic Diagnosis of Hepatocellular Carcinoma
    Woo Kyoung Jeong
    The Korean Journal of Gastroenterology.2021; 78(5): 261.     CrossRef
  • Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint
    Nese Karadag Soylu
    Journal of Gastrointestinal Cancer.2020; 51(4): 1176.     CrossRef
Close layer

JLC : Journal of Liver Cancer
TOP